Archive for the ‘neuroscience’ category: Page 833
Mar 22, 2018
Powerful New Algorithm Is a Big Step Towards Whole-Brain Simulation
Posted by Carse Peel in categories: computing, information science, neuroscience
The renowned physicist Dr. Richard Feynman once said: “What I cannot create, I do not understand. Know how to solve every problem that has been solved.”
An increasingly influential subfield of neuroscience has taken Feynman’s words to heart. To theoretical neuroscientists, the key to understanding how intelligence works is to recreate it inside a computer. Neuron by neuron, these whizzes hope to reconstruct the neural processes that lead to a thought, a memory, or a feeling.
With a digital brain in place, scientists can test out current theories of cognition or explore the parameters that lead to a malfunctioning mind. As philosopher Dr. Nick Bostrom at the University of Oxford argues, simulating the human mind is perhaps one of the most promising (if laborious) ways to recreate—and surpass—human-level ingenuity.
Continue reading “Powerful New Algorithm Is a Big Step Towards Whole-Brain Simulation” »
Mar 22, 2018
Lana Awad is engineering the neuro-tech that will transform humanity
Posted by Carse Peel in categories: biotech/medical, business, Elon Musk, engineering, internet, military, neuroscience
Perfect vision is great. But like any advantage it comes with limitations. Those with ease don’t develop the same unique senses and strengths as someone who must overcome obstacles, people like Lana Awad, a neurotech engineer at CTRL-labs in New York, who diagnosed her own degenerative eye disease with a high school science textbook as a teen in Syria and went on to teach at Harvard University.
Though they see themselves as clear leaders, visionaries with all the obvious advantages—like Elon Musk and Mark Zuckerberg, for example—can be blind in their way, lacking the context needed to guide if they don’t recognize their counterintuitive limitations. This is problematic for humanity because we’re all relying on them to create the tools that increasingly rule every aspect of our lives. The internet is just the start.
Tools that will meld mind and machine are already a reality. Neurotech is a huge business with applications being developed for gaming, the military, medicine, social media, and much more to come. Neurotech Report projected in 2016 that the $7.6 billion market could reach $12 billion by 2020. Wired magazine called 2017, “a coming-out year for the brain machine interface (BMI).”
Continue reading “Lana Awad is engineering the neuro-tech that will transform humanity” »
Mar 22, 2018
TELEPATHIC superhumans could be a reality ‘within decades’
Posted by Carse Peel in categories: biotech/medical, cyborgs, neuroscience
According toDr Eric Leuthardt, a brain surgeon at Washington University in St. Louis, neural prosthetics will become mainstream in the coming decades (stock image).
Mar 22, 2018
Worn Like a Helmet, a New Brain Scanner Aims to Make It Easier to Treat Kids with Epilepsy
Posted by Genevieve Klien in categories: electronics, neuroscience
Lightweight equipment is not much larger than what a bicyclist would wear.
- By Megan Thielking, STAT on March 22, 2018
Mar 22, 2018
New algorithm will allow for simulating neural connections of entire brain on future exascale supercomputers
Posted by Genevieve Klien in categories: information science, mathematics, neuroscience, supercomputing
Amazing.
Mar 21, 2018
Gut microbes are vulnerable to wide range of drugs
Posted by Amnon H. Eden in categories: biotech/medical, neuroscience
Take your probiotics seriously. Even a headache pill may weaken your gut bacteria, a condition linked to obisity, depression, alzheimer’s, and dementia.
Mar 21, 2018
A drug to slow spread of dementia could be available in three years
Posted by Dan Kummer in categories: biotech/medical, neuroscience
A drug to slow the spread of dementia could be available in three years and a ‘vaccine’ that prevents the disease within a decade, experts say.
- It is now a matter of ‘when not if’ a cure will be found for Alzheimer’s
- Last year dementia became Great Britain’s number one cause of death
- Existing drugs for Alzheimer’s only treat the symptoms, not causes
By Colin Fernandez for the Daily Mail
Continue reading “A drug to slow spread of dementia could be available in three years” »
Mar 20, 2018
Targeting levels of specific protein could improve memory in aging, reduce symptoms of PTSD
Posted by Nicholi Avery in categories: biotech/medical, genetics, life extension, neuroscience
A neural circuit mechanism involved in preserving the specificity of memories has been identified by investigators from the Massachusetts General Hospital (MGH) Center for Regenerative Medicine and the Harvard Stem Cell Institute (HSCI).
They also identified a genetic “switch” that can slow down #memory generalization — the loss of specific details over time that occurs in both age-related memory impairment and in post-traumatic stress disorder (#PTSD), in which emotions originally produced by traumatic experiences are elicited in response to innocuous cues that have little resemblance to the traumatic memory.
“The circuit mechanism we identified in mice allows us to preserve the precision or the details of memories over the passage of time in adult as well as aged animals,” says Amar Sahay of the MGH Center for #Regenerative Medicine and HSCI, corresponding author of a paper appearing in Nature Medicine. “These findings have implications for the generalization of traumatic memories in PTSD and for memory imprecision in #aging.”
Mar 20, 2018
Drugs to vaccinate over-50s against Alzheimer’s could be here in a decade…with a £ 9bn price tag
Posted by Genevieve Klien in categories: biotech/medical, neuroscience
D rugs to vaccinate everyone over the age of 50 against Alzheimer’s could be available within 10 years, but would cost the NHS £9 billion, a new report has shown.
New analysis commissioned by Alzheimer’s Research UK found that drugs to halt, slow or reverse the disease could be available in as little as three years with major vaccine and screening programmes possible within a decade.
But dementia experts warned that demand from patients would be ‘instant and huge’ and called on the NHS to act now to make sure funds were in place for when the breakthroughs occurred.